# Treatment of Hypoactive Delirium and Outcome Measures

> **NCT02345902** · PHASE3 · UNKNOWN · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 60 (estimated)

## Conditions studied

- Hypoactive Delirium

## Interventions

- **DRUG:** Haloperidol
- **OTHER:** Placebo
- **OTHER:** non-pharmacologic measures

## Key facts

- **NCT ID:** NCT02345902
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2018-03
- **Final completion:** 2018-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02345902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02345902, "Treatment of Hypoactive Delirium and Outcome Measures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02345902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*